Magnets can cure blood infections, HIV, Ebola virus and sepsis – study

Scientists reveal that they found a way to use magnets to help cure blood infections; the magnets remove toxins, bacteria, fungi, and other pathogens from the blood, reports the Daily Star.

Studies performed on rats have shown great potential in drawing away these harmful materials from inside the body, offering cure for deadly illnesses such as the Ebola virus and sepsis.

Targets pathogens to cleanse the blood

Dubbed as the “bio-spleen”, the invention makes use of genetically-engineered human blood protein coating nanobeads. These nano-beads act as an artificial spleen, targeting the pathogens and toxins in the blood. These harmful substances bind to the nano-beads, which are then drawn out of the body using magnets.

The process would be similar to a dialysis wherein the ‘dirty’ blood is drawn out of the body while the ‘clean’ blood is returned to the circulatory system.

The good news is that this has proven to be effective in drawing out a wide range of toxins and pathogens.

Treatment against several viruses, including HIV?

In mice infected with various types of viruses and pathogens, including Escherichia coli and Staphylococcus aureus, the bio-spleen was able to remove 90% of the pathogens. If this effectiveness can be replicated in people, then this new discovery can definitely save a lot of lives.

What makes the researchers even more excited about this new finding is that the nano-beads show ability to bind with HIV and Marburg viruses as well as the Ebola and sepsis viruses.

The bad news is that this has only been tested on mice and it could take several more years before this magnetic bio-spleen can be proven safe for use on humans. Still, the discovery paves the way for future treatments in blood infections such as sepsis and Ebola which are not just deadly but also spread easily from one infected person to another.

According to the report, the newly discovered magnetic treatment needs to be tested on larger animals, then on human test subjects before it can be approved as an alternative treatment against bad blood cases and blood infections.